Prostate apoptosis response-4 and tumor suppression: it’s not just about apoptosis anymore

Author:

Cheratta Anees Rahman,Thayyullathil Faisal,Pallichankandy Siraj,Subburayan Karthikeyan,Alakkal Ameer,Galadari SehamuddinORCID

Abstract

AbstractThe tumor suppressor prostate apoptosis response-4 (Par-4) has recently turned ‘twenty-five’. Beyond its indisputable role as an apoptosis inducer, an increasing and sometimes bewildering, new roles for Par-4 are being reported. These roles include its ability to regulate autophagy, senescence, and metastasis. This growing range of responses to Par-4 is reflected by our increasing understanding of the various mechanisms through which Par-4 can function. In this review, we summarize the existing knowledge on Par-4 tumor suppressive mechanisms, and discuss how the interaction of Par-4 with different regulators influence cell fate. This review also highlights the new secretory pathway that has emerged and the likely discussion on its clinical implications.

Funder

New York University Abu Dhabi

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Reference138 articles.

1. Sells, S. F. et al. Commonality of the gene programs induced by effectors of apoptosis in androgen-dependent and -independent prostate cells. Cell Growth Differ. 5, 457–466 (1994).

2. El-Guendy, N., Zhao, Y., Gurumurthy, S., Burikhanov, R. & Rangnekar, V. M. Identification of a unique core domain of par-4 sufficient for selective apoptosis induction in cancer cells. Mol. Cell Biol. 23, 5516–5525 (2003).

3. Hebbar, N., Wang, C. & Rangnekar, V. M. Mechanisms of apoptosis by the tumor suppressor Par-4. J. Cell Physiol. 227, 3715–3721 (2012).

4. El-Guendy, N. & Rangnekar, V. M. Apoptosis by Par-4 in cancer and neurodegenerative diseases. Exp. Cell Res. 283, 51–66 (2003).

5. Boehrer, S. et al. In lymphatic cells par-4 sensitizes to apoptosis by down-regulating bcl-2 and promoting disruption of mitochondrial membrane potential and caspase activation. Cancer Res 62, 1768–1775 (2002).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3